The ALTACE ® Opportunity

• HOPE Patients Not Being Treated with an ACE Inhibitor

• Market Potential = 20 Million Patients

  • Diabetes
  • Coronary Artery Disease
  • Stroke & PVD

• AHA Guidelines Recommend Use of ALTACE in Diabetics to Prevent Stroke

  • 16 Million Americans with Diabetes
  • 60% of Diabetics Die of Heart or Blood Vessel Disease
  • Patients with Diabetes Who Took ALTACE
    • 33% Reduction in Risk of Stroke

Previous slide

Next slide

Back to first slide

View graphic version